Syngene International has announced several significant changes within its Senior Management Personnel, effective across April and May 2026. These movements include the departure of three key executives by mutual consent and the immediate appointment of their successors to critical roles within the Executive Committee. The transitions ensure continuity in commercial, human resources, and strategic functions.
Syngene Announces Senior Management Transitions for Q1 2026
Syngene International Limited has formally communicated significant changes concerning its Senior Management Personnel, effective near the close of the current fiscal year. These announcements cover both executive departures and new appointments across vital operational areas.
Departures by Mutual Consent (Effective April 30, 2026)
Three members of the Executive Committee have elected to leave the company by mutual consent to pursue other career opportunities, with their last day being April 30, 2026:
- Ms. Caroline Hempstead, Chief Commercial Officer (Interim).
- Mr. Andrew Webster, Chief Human Resources Officer.
- Dr. Kenneth Barr, Head of SynVent and Strategic Collaborations.
New Appointments Effective May 1, 2026
To ensure seamless transition and leadership continuity, the company has appointed new leaders, effective May 1, 2026, who will also serve as members of the Executive Committee:
- Mr. Abhijit Zutshi appointed as the new Chief Commercial Officer.
- Ms. Maninder Singh Puri appointed as the new Chief Human Resources Officer.
Profiles of Incoming Leadership
The company provided detailed profiles for the incoming leaders, highlighting extensive prior experience:
Mr. Abhijit Zutshi (Chief Commercial Officer)
Mr. Zutshi currently serves as the Chief Commercial Officer of Biocon Limited, overseeing Generics business Commercial operations. His career at Biocon spans over two decades, involving instrumental roles in setting up commercial infrastructure in the U.S. and leading the Formulations business across geographies. He holds a Bachelor’s degree in Pharmaceutical Science and has attended the Harvard Business School’s Program for Leadership Development.
Ms. Maninder Singh Puri (Chief Human Resources Officer)
Ms. Puri is currently the Head of Human Resources for Biocon’s Generics Business and Biocon Academy. With a professional journey exceeding 25 years, she has held leadership roles at major firms including Accenture and iGATE. Notably, she was recognized as “CHRO for the year 2022.” Ms. Puri holds a Master’s in English Literature and a CHRO degree from Wharton Business School.
All details regarding these changes, as required by applicable disclosure norms, are provided in the Annexure to the formal notification dated March 6, 2026.
Source: BSE
